Bessemer Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3K Buy
+29
New +$2.91K ﹤0.01% 2354
2026
Q1
Sell
-2
Closed 2620
2025
Q4
$0 Hold
2
﹤0.01% 2642
2025
Q3
$0 Buy
+2
New +$127 ﹤0.01% 2625
2024
Q4
Sell
-30
Closed -$1K 2593
2024
Q3
$1K Buy
+30
New +$1.2K ﹤0.01% 2472

Other funds holding MIRM

Bessemer Group's MIRM Position: Q2 2026 in Review

Bessemer Group opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 29 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #2354 among its holdings. This is a return to the name: Bessemer Group previously reported a position in MIRM as recently as Q4 2025.

Bessemer Group first reported a position in MIRM in Q3 2024 and has held it in 4 quarters since. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Bessemer Group held 29 shares of Mirum Pharmaceuticals worth $3K as of Q2 2026.
  • Mirum Pharmaceuticals was a new Bessemer Group position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2354 holding.
  • Bessemer Group first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.